A practical reference on retention time: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-04-30 and is reviewed periodically as new material appears.
Detection in HPLC testing commonly relies on ultraviolet-visible absorbance, fluorescence, refractive index, or mass spectrometry. A diode array detector records full spectra across a wavelength range, which helps identify co-eluting peaks. Mass spectrometry provides mass-to-charge ratios and can confirm molecular identity at low concentrations. The choice of detector depends on analyte structure, required sensitivity, and whether quantitation or identification is the goal. No single detector works for every compound, and method development often compares responses before selecting one.
High-performance liquid chromatography is an analytical technique that separates components of a liquid sample by passing it through a packed column under pressure. A pump delivers a mobile phase at a controlled flow rate, and an injector introduces the sample into the stream. Differences in interaction with the stationary phase cause analytes to migrate at different rates. Detectors record elution as peaks, and a data system converts signals into a chromatogram. The method is suited to compounds that dissolve in a liquid and are not volatile enough for gas chromatography.
Routine quality control includes blanks, duplicates, spiked samples, and certified reference materials. Calibration curves are prepared with standards at several concentrations, and the detector response is checked for linearity. Carryover, column aging, mobile phase evaporation, and temperature drift can shift retention times or peak areas. Maintenance such as replacing seals, filters, and columns helps prevent failures. Records of injections, integration, and deviations support traceability. Audits may request raw data and instrument logs for each batch.
Developing an HPLC test begins with defining the analytes, matrix, and required reporting limits. Chemists select a separation mode, column chemistry, mobile phase composition, flow rate, and detection wavelength or mass transition. Experiments then adjust these variables to achieve adequate retention, resolution, and peak shape. System suitability tests confirm that the instrument and method perform consistently before sample analysis. Without suitable resolution, quantitative results may be unreliable. Preliminary runs often use scouting gradients to locate retention windows.
| Property | Value | Notes |
|---|---|---|
| Separation mode | Reversed-phase | Most common for neutral and moderately polar analytes |
| Column particle size | 3–5 µm | Smaller particles improve resolution but raise backpressure |
| Mobile phase pH range | 2–8 | Silica-based columns may degrade outside this range |
| Typical flow rate | 1.0–2.0 mL/min | For analytical columns with 4.6 mm internal diameter |
| Common synonyms | HPLC, LC, high-pressure liquid chromatography | High-performance liquid chromatography is the standard expansion |
Practical HPLC testing depends on careful sample preparation and instrument maintenance. Samples may require filtration, dilution, pH adjustment, or extraction to avoid column damage and matrix interference. Mobile phases are degassed and filtered, and columns are equilibrated before injection. Common problems include peak tailing, baseline drift, ghost peaks, carryover, and co-elution of analytes. Documentation of instrument logs, calibration records, and electronic audit trails supports data integrity and traceability. Ongoing training and routine maintenance help reduce variability between analysts and laboratories.
Quality control laboratories use HPLC to check identity, purity, concentration, and stability of raw materials and finished products. A validated method specifies the column, mobile phase, flow rate, detection wavelength, injection volume, and run time. Samples are prepared and compared against reference standards of known concentration. The resulting chromatogram provides quantitative data, such as assay values and impurity levels. This approach is common in pharmaceutical, food, environmental, and industrial testing where consistent measurements are required.
Method validation demonstrates that an analytical procedure is suitable for its intended purpose. Typical validation characteristics include accuracy, precision, specificity, linearity, range, limit of detection, limit of quantitation, and robustness. Regulatory guidance from bodies such as the International Council for Harmonisation and the United States Pharmacopeia outlines expectations, though specific criteria depend on the product and method. System suitability tests are run before sample analysis to confirm resolution, peak symmetry, column efficiency, and injection repeatability. Failure of these checks can invalidate a batch of measurements.
HPLC testing is not a single fixed procedure; it is a family of separation modes. Reversed-phase, normal-phase, ion-exchange, size-exclusion, and affinity chromatography each suit different analyte properties. Reversed-phase methods dominate because they handle many neutral and moderately polar compounds. Detection can be optical, electrochemical, or mass spectrometric, and the detector dictates what information is available. Coupling with mass spectrometry increases selectivity and enables identification when standards are unavailable. The technique cannot separate every mixture without adjustment.
HPLC testing is an analytical technique used to separate, identify, and quantify components in a liquid sample. It relies on a pressurized mobile phase that carries the sample through a column packed with stationary phase. Different compounds travel at different rates because of interactions with the stationary and mobile phases. The resulting signal versus time is a chromatogram. Peak position indicates identity under specified conditions, while peak area or height relates to amount.
Laboratories apply HPLC testing across pharmaceutical, food, environmental, and industrial chemistry. The method can measure active ingredients, impurities, additives, preservatives, and degradation products. Sample preparation often includes dilution, filtration, and sometimes extraction or derivatization. The choice of column, mobile phase, pH, temperature, and detector depends on the analytes and matrix. Results are compared with reference standards to assign identity and concentration. Method suitability is judged by resolution, precision, and accuracy.
Routine quality control uses system suitability, blank injections, check standards, and control samples to detect drift or contamination. System suitability criteria may specify minimum resolution, maximum tailing factor, and a permitted range for repeated injections. Blank injections reveal carryover or solvent contamination, while check standards confirm calibration accuracy over a batch. Control samples with known analyte levels can show whether results remain within statistical limits. When a control result falls outside limits, the analyst investigates the cause and may invalidate affected results before repeating the batch.
Documentation and traceability are central to regulated HPLC testing. Records typically include instrument logs, column history, mobile-phase preparation, sample preparation, injection sequences, raw chromatograms, and audit trails. Electronic systems may require user access controls, time-stamped changes, and backup procedures. Training records show that analysts are qualified for assigned methods. Audits and inspections check whether written procedures match actual practice and whether deviations are documented. These controls support reproducibility and allow results to be reconstructed if questions arise later.
Method validation establishes that an HPLC procedure is suitable for its intended purpose. Typical parameters include accuracy, precision, specificity, linearity, range, limit of detection, limit of quantitation, robustness, and solution stability. Accuracy reflects closeness to a reference value, while precision reflects agreement among repeated measurements. Specificity shows whether the method can measure the analyte without interference from matrix components. Validation is documented through protocols and reports, and the required extent depends on the method's use and regulatory context.
Routine HPLC testing depends on controlled reagents, calibrated instruments, and documented procedures. Columns degrade over time, so retention times and peak shapes are monitored for drift. Mobile phases are filtered and degassed to prevent pump damage and detector noise. Reference standards must be traceable and stored under suitable conditions. Data handling systems record injections, calculations, and audit trails. Quality control samples interspersed with unknowns help detect errors during a run.
Developing an HPLC method begins with defining the purpose, such as quantifying a main component, measuring impurities, or confirming identity. Analysts select separation mode, column, mobile phase, detection, and sample preparation based on analyte properties and matrix. Experiments vary solvent strength, pH, buffer type, and temperature to achieve resolution between critical peaks. The goal is a robust method that produces reliable results across instruments and operators. Method development often involves trial runs and statistical optimization.
Challenges include: 1) finding a surface and a method of attachment that allows the proteins to maintain their secondary or tertiary structure and thus their biological activity and their interactions with other molecules, 2) producing an array with a long shelf life so that the proteins on the chip do not denature over a short time, 3) identifying and isolating antibodies or other capture molecules against every protein in the human genome, 4) quantifying the levels of bound protein while assuring sensitivity and avoiding background noise, 5) extracting the detected protein from the chip in order to further analyze it, 6) reducing non-specific binding by the capture agents, 7) the capacity of the chip must be sufficient to allow as complete a representation of the proteome to be visualized as possible; abundant proteins overwhelm the detection of less abundant proteins such as signaling molecules and receptors, which are generally of more therapeutic interest.
== Management == Opioid use disorders typically require long-term treatment and care with the goal of reducing the person's risks and improving their long-term physical and psychological condition. First-line management involves the use of opioid replacement therapies, particularly methadone, naltrexone, morphine, hydromorphone, buprenorphine/naloxone (Suboxone), and diamorphine (heroin), which is the most effective treatment option of all drugs. Withdrawal management alone is strongly discouraged, because of its association with elevated risks of HIV and hepatitis C transmission, high rates of overdose deaths, and nearly universal relapse. This approach is seen as ineffective without plans for transition to long-term evidence-based addiction treatment, such as opioid agonist treatment. Though treatment reduces mortality rates, the first four weeks after treatment begins and the four weeks after treatment ceases are the riskiest times for drug-related deaths. These periods of increased vulnerability are significant because many of those in treatment leave programs during these periods. There is evidence that people with opioid use disorder who are dependent on pharmaceutical opioids may require a different management approach from those who take heroin.
Plasminogen activators are serine proteases that catalyze the activation of plasmin via proteolytic cleavage of its zymogen form plasminogen. Plasmin is an important factor in fibrinolysis, the breakdown of fibrin polymers formed during blood clotting. There are two main plasminogen activators: urokinase (uPA) and tissue plasminogen activator (tPA). Tissue plasminogen activators are used to treat medical conditions related to blood clotting including embolic or thrombotic stroke, myocardial infarction, and pulmonary embolism. Plasminogen activators are inhibited by plasminogen activator inhibitor-1, plasminogen activator inhibitor-2, and protein C inhibitor.
=== Regional === Rabbi Eliyahu Zini, the uncle of Shin Bet Chief David Zini, criticized the agreement with the Lebanese government, asserting, "all of Lebanon belongs to us." He questioned Israeli ministers, asking, "Are you normal? You are giving up the inheritance of our ancestors on what basis?". Hezbollah expressed conditional acceptance of the ceasefire, warning that Israeli military presence in Lebanon would justify continued resistance. Lebanese political figures advised civilians to delay returning to affected areas until the terms and stability of the agreement became clearer.
=== Role in tumor growth === Endothelial progenitor cells are likely important in tumour growth and are thought to be critical for metastasis and the angiogenesis. A large amount of research has been done on CFU-Hill bone marrow-derived putative EPCs. Ablation of the endothelial progenitor cells in the bone marrow lead to a significant decrease in tumour growth and vasculature development. This indicates that endothelial progenitor cells present novel therapeutic targets. Inhibitor of DNA Binding 1 (ID1) has been used as a marker for these cells; this allows for tracking EPCs from the bone marrow to the blood to the tumour-stroma and even incorporated in tumour vasculature. Recently it has been found that miRNAs regulate EPC biology and tumour angiogenesis. This work by Plummer et al. found that in particular targeting of the miRNAs miR-10b and miR-196b led to significant defects in angiogenesis-mediated tumor growth by decreasing the mobilization of proangiogenic EPCs to the tumour. These findings indicate that directed targeting these miRNAs in EPCs may result in a novel strategy for inhibiting tumor angiogenesis. Studies have shown ECFCs and human umbilical vein endothelial cells (HUVECs) to have a capacity for tumor migration and neoangiogenesis even greater than that of other CD34+ hematopoietic cells when implanted in immunodeficient mice, suggesting the endothelial progenitors play a key role, but further supporting the importance of both cell types as targets for pharmacological therapy.
Sources: en.wikipedia.org
Tim Hortons is popularly known as "Timmies" or "Timmy's". The ubiquity of Tim Hortons, through the wide expansion of its outlets, makes it a prominent feature of Canadian life; Canadians eat more donuts per capita and have more donut outlets per capita than any other nation. Tim Hortons' prevalence in the coffee and donut market has led to its branding as a Canadian cultural icon. The media routinely refer to its iconic status, despite this being a relatively recent development; there were only a few outlets before the chain's expansion in the late 1990s and 2000s. A series of Tim's television commercials promotes this idea by showing vignettes of Canadians abroad and their homesickness for Tim Hortons. Canadian author Pierre Berton once wrote: "In so many ways the story of Tim Hortons is the essential Canadian story. It is a story of success and tragedy, of big dreams and small towns, of old-fashioned values and tough-fisted business, of hard work and of hockey." Commentator Rex Murphy posited that the reason Tim Hortons "transmuted into a hallowed piece of Canadiana" was perhaps consumers' "reverse-preference" against the sudden penetration of Starbucks in the 1990s. Other commentators have bemoaned the rise of Tim Hortons as a national symbol.
On July 9, Trump reversed a previously suspended military aid package to Ukraine following Russia's largest aerial assault on the country, involving hundreds of drones and missiles. The suspension, reportedly authorized by senior defense officials without Trump's prior knowledge. Trump expressed growing frustration with Russian president Vladimir Putin, accusing him of insincerity and relentless aggression, saying, "He wants to go all the way, just keep killing people, it's no good." The U.S. are discussing sending 10 Patriot missiles to Ukraine, and Trump said he is reviewing a proposed sanctions bill by Senator Lindsey Graham that would impose 500% tariffs on countries trading with Russia. Although Trump has previously mentioned secondary sanctions, none have been implemented so far, with the president citing their cost and waiting to see if a peace deal would emerge. On July 14, 2025, Trump threatened to impose 100% tariffs and secondary sanctions on countries purchasing Russian oil if Russia did not agree to a ceasefire within 50 days. Trump confirmed a summit meeting between him and Putin to be held on August 15, 2025, in Alaska The high-level summit at Joint Base Elmendorf–Richardson in Anchorage concluded without progress toward a ceasefire. Following the talks, Trump suggested the United States could assist Ukraine with surveillance flights or air defense support, while ruling out the deployment of ground troops.
In October 2020, GSK told some staff that while at work they should disable the contact tracing function of the NHS test-and-trace app which monitors the spread of COVID-19. GSK explained the reason for this was due to social distancing measures in place at their sites rendering the technology unnecessary. In November 2023, GSK filed a lawsuit against Moderna Inc. in U.S. federal court in Delaware, accusing the company of violating GSK's patents related to messenger RNA (mRNA) technology. The lawsuit claims that Moderna's COVID-19 vaccine Spikevax and RSV vaccine mResvia infringe on several of GSK's patents, particularly those related to lipid nanoparticles used for delivering mRNA into the human body. This legal action follows a similar lawsuit GSK filed against Pfizer and BioNTech earlier in 2024, also over patent infringement concerning their mRNA-based COVID-19 vaccine. The current litigation seeks unspecified monetary damages from Moderna.
The total synthesis of bottromycin was accomplished in 2009. The synthesis was achieved in 17 steps. Although bottromycin is a peptide-based natural product, it contains an unusual macrocycle and thiazole heterocycle, so that the total synthesis could not be accomplished using traditional solid-phase peptide synthesis. The synthesis was accomplished using a combination of peptide coupling and other methods. To obtain the primary thia-β-Ala-OMe intermediate, a sequence of condensation, Mannich reaction, and palladium-catalyzed decarboxylation steps were performed. This intermediate was prepared stereoselectively. To obtain the amidine linkage, a tripeptide intermediate was coupled to a phthaloyl-protected thioamide via mercury-mediated condensation using mercury (II) trifluoromethanesulfonate (Hg(OTf)2) to yield a branched amidine intermediate. To obtain the final product macrocycle, macrolactamization of the amidine-containing intermediate was required. Macrolactamization was performed with 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDCI) and iPr2NEt yielded the final product, bottromycin A2. To confirm that the synthesized bottromycin A2 had the same stereochemistry as natural bottromycin A2, the product was studied by optical rotation, 1H and 13C NMR, IR, and HRMS. The data was found to match that of isolated bottromycin A2. Further, the synthetic sample of bottromycin was also found to have antibacterial activity against both MRSA and VRE, although quantitative data was not reported.
Notable awards that Ramachandran received include the Shanti Swarup Bhatnagar Award for Physics in India (1961) and the Fellowship of the Royal Society of London. In 1999, the International Union of Crystallography honoured him with the Ewald Prize for his 'outstanding contributions to crystallography'. He was nominated for the Nobel Prize as well for his fundamental contributions in protein structure and function.
Sources: en.wikipedia.org
Chlorpromazine has been found to increase propranolol levels by 1.7-fold. The non-selective CYP450 inhibitor cimetidine has been found to increase peak propranolol levels by 1.4-fold and area-under-the-curve levels by 1.5-fold. Cigarette smoking, which induces CYP1A2, has been found to increase the clearance of propranolol by 77%, resulting in decreased propranolol concentrations. The lipid-lowering drugs cholestyramine and colestipol decreased propranolol levels by up to 50%. Aluminum hydroxide gel may decrease propranolol levels. Alcohol may increase propranolol levels.
While negotiating with Alpachi for the hostages' release, Umeko realizes the truth and clears his name, while her teammates rescue Alpachi's son and delete Goldom. Attika Alpachi is voiced by Bin Shimada. Shinnooian Hakutaku (シンノー星人ハクタク, Shinnō Seijin Hakutaku): A wise woman from Planet Shinoo, with knowledge of all space herbs, who occasionally assumes the form of a human teenage girl and possesses a third eye shaped like a red jewel. After the Dekarangers take her into their protective custody, she provides guidance to Sen-chan, becomes attracted to him, and raises money for their wedding. Hakutaku is voiced by Reiko Suzuki (鈴木 れい子, Suzuki Reiko) while her human form is portrayed by Narumi Konno (近野 成美, Kon'no Narumi). Bandarean Jeeva (バンダレ星人ジーバ, Bandare Seijin Jība): A physically imposing Oni-themed alien, and champion boxer in Durden's illegal fight club, from Planet Bandare. After consuming Durden's steroid, Megagesterine, and gaining wing-like horns on his arms and neck, Jeeva fights Hoji, who defeats him. Following this, Jeeva reformed and found work as the assistant director of a television station. Jeeva is voiced by Toshitsugu Takashina (高階 俊嗣, Takashina Toshitsugu). Slorpean Faraway (スロープ星人ファラウェイ, Surōpu Seijin Farawei): A small-time criminal from Planet Slorpe who resembles a ganguro girl and possesses proficient hacking skills.
==== Teenage mode ==== China heavily regulates how Douyin is used by minors in the country, especially after 2018. Under government pressure, ByteDance introduced parental controls and a "teenage mode" that shows only whitelisted content, such as knowledge sharing, and bans pranks, superstition, dance clubs, and pro-LGBT content. A mandatory screen time limit was put in place for users under the age of 14 and a requirement to link accounts to a real identity to prevent minors from lying about their age or using an adult's account. The differences between Douyin and TikTok have led some US politicians and commentators to accuse the company or the Chinese government of malicious intent. In March 2023, TikTok announced default screen time limits for users under the age of 18. Those under the age of 13 would need a passcode from their parents to extend their time.
=== Fertility support === Progesterone is used for luteal support in assisted reproductive technology (ART) cycles such as in vitro fertilization (IVF). It is also used to correct luteal phase deficiency to prepare the endometrium for implantation in infertility therapy and is used to support early pregnancy.
=== Biomaterials === Hydrogels are three-dimensional network structures with high hydrophilicity that can absorb and retain large amounts of water. Due to their excellent biocompatibility, they are widely used in the field of biomaterials. The main feature of hydrogels is their high water content, which is similar to the aqueous environment in biological systems, making them ideal for applications in tissue engineering, drug delivery, wound dressings, and artificial skin. Hydrogels can be classified into natural and synthetic types. Natural hydrogels, such as gelatin and chitosan, are derived from biological materials and offer good biodegradability and biocompatibility. Synthetic hydrogels, on the other hand, typically have higher mechanical strength and tunability but may exhibit lower biocompatibility. Additionally, hydrogels can be categorized as environmental-responsive or non-responsive based on their response to external stimuli. Environmental-responsive hydrogels, which can react to changes in temperature, pH, or ion concentration, are particularly useful in drug delivery systems. Due to their tunability, hydrogels continue to expand their applications in the biomedical field and are expected to play a crucial role in various medical applications in the future. Implanted or injected hydrogels have the potential to support tissue regeneration by mechanical tissue support, localized drug or cell delivery, local cell recruitement or immunomodulation, or encapsulation of nanoparticles for local photothermal therapy or brachytherapy.
Sources: en.wikipedia.org
HPLC testing separates and quantifies components in a liquid sample. It is used to check identity, purity, concentration, or stability. The technique works best for compounds that dissolve and are not easily vaporized.
The pump maintains a steady flow rate and pressure, which keeps retention times reproducible. Pulsation or flow errors can shift peaks and distort quantitation. Modern pumps use feedback control to reduce these variations.
HPLC alone usually separates compounds but does not always identify them. Retention time matching with a known standard provides tentative identification. Coupling HPLC to mass spectrometry adds mass information that supports structural identification.
System suitability is a set of checks performed before and during a run to confirm that the instrument, column, and method work as expected. Common checks include resolution, tailing factor, theoretical plates, and relative standard deviation of replicate injections. Failure triggers troubleshooting or method adjustment.